In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...
Via well-designed AI tools and workflows, trial sponsors are aiming to unify cross-functional data ecosystems to enable a ...
While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...
Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...
Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...
There are nearly 300 data centers in Northern Virginia, scattered across Loudoun, Fairfax and Prince William counties. It's the largest concentration of data centers in the world. The increase in ...
The MCED test shows similar performance in cancer survivors and the general population, with a PPV of 50% and high ...
As enterprises modernize, the question is no longer whether to use SAP or non-SAP tools, but how to make them work together ...
Over the past two years, Generative AI (GenAI) has captured global attention, including here in Kenya, thanks to its ability to draft content, summarise reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback